IRIDEX Director Sells $21,929 in Stock (IRIX)
IRIDEX (NASDAQ:IRIX) Director James B. Hawkins sold 2,714 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $8.08, for a total transaction of $21,929.12. Following the completion of the sale, the director now directly owns 31,294 shares of the company’s stock, valued at approximately $252,856. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of IRIDEX (NASDAQ:IRIX) traded up 0.13% on Friday, hitting $7.89. 9,148 shares of the company’s stock traded hands. IRIDEX has a 1-year low of $5.72 and a 1-year high of $11.00. The stock has a 50-day moving average of $7.93 and a 200-day moving average of $8.48. The company has a market cap of $77.9 million and a price-to-earnings ratio of 48.94.
IRIDEX Corporation is a worldwide provider of therapeutic based laser systems, delivery devices and consumable instrumentation used to treat eye diseases in ophthalmology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.